Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
Sign Up to like & getrecommendations! Published in 2024 at "Acta Neuropathologica"
DOI: 10.1007/s00401-024-02736-8
Abstract: Pituitary neuroendocrine tumors (PitNETs) exhibiting aggressive, treatment-refractory behavior are the rare subset that progress after surgery, conventional medical therapies, and an initial course of radiation and are characterized by unrelenting growth and/or metastatic dissemination. Two… read more here.
Keywords: aggressive treatment; refractory behavior; treatment; treatment refractory ... See more keywords
Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC
Sign Up to like & getrecommendations! Published in 2021 at "Current Oncology"
DOI: 10.3390/curroncol28010059
Abstract: Background: Studies have shown that aggressive treatment of non-small cell lung cancer (NSCLC) with oligometastatic disease improves the overall survival (OS) compared to a palliative approach and some immunotherapy checkpoint inhibitors, such as anti-programmed cell… read more here.
Keywords: oligometastatic nsclc; treatment; aggressive treatment; group ... See more keywords